Home / Journals / CJU / Vol.25, No.5, 2018
Special Issues
  • Open AccessOpen Access

    EDITORIAL

    Why Doesn’t Everyone Want To Be A Urologist, Our Tomorrows Will Be Better Than Our Yesterdays

    Kevin R. Loughlin
    Canadian Journal of Urology, Vol.25, No.5, pp. 9467-9468, 2018
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    LEGENDS IN UROLOGY

    LEGENDS IN UROLOGY

    Lawson Douglas
    Canadian Journal of Urology, Vol.25, No.5, pp. 9469-9471, 2018
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    BOOK REVIEW

    Prostate Cancer: Clinical Case Scenarios

    Sam S. Chang, Michael S. Cookson
    Canadian Journal of Urology, Vol.25, No.5, pp. 9472-9472, 2018
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    ARTICLE

    Cystectomy for benign disease: readmission, morbidity, and complications

    Scott G. Erpelding1, Adam Dugan2, Sudhir Isharwal3, Stephen Strup1, Andrew James1, Shubham Gupta1
    Canadian Journal of Urology, Vol.25, No.5, pp. 9473-9479, 2018
    Abstract Introduction: We sought to elucidate outcomes and risks associated with cystectomy and urinary diversion for benign urological conditions compared to malignant conditions.
    Materials and methods: We identified patients who underwent cystectomy and urinary diversion for benign and malignant diseases through the American College of Surgeons National Surgery Quality Improvement Program database for the period 2007-2015. Patients were selected for inclusion based upon their current procedure terminology and International Classification of Disease, Ninth Revision codes. Primary outcome was 30-day morbidity, including return to the operating room (OR); infectious, respiratory, and/or cardiovascular complications; readmission to the hospital; and mortality.… More >

  • Open AccessOpen Access

    ARTICLE

    Health-related quality of life after BCG or MMC induction for non-muscle invasive bladder cancer

    Salvatore Siracusano1, Tommaso Silvestri2, Silvia Bassi1, Antonio Benito Porcaro1, Maria Angela Cerruto1, Renato Talamini3, Walter Artibani1
    Canadian Journal of Urology, Vol.25, No.5, pp. 9480-9485, 2018
    Abstract Introduction: To evaluate health-related quality of life (HRQoL) in patients with non-muscle invasive bladder cancer (NMIBC) during the induction phase of intravesical instillations with BCG or MMC.
    Materials and methods: HRQoL was measured by two questionnaires from EORTC (QLQ-C30 and QLQ-BLS24), stratifying results by gender, age, and therapy at the start of the therapy (T0), at the last instillation (T1), and at 3 months after T1 (T2). The persistence of QoL-related side effects after 3 months from the end of the induction cycle was evaluated.
    Results: We enrolled 108 naïve patients, and 103 patients self-completed the questionnaires. Treatment… More >

  • Open AccessOpen Access

    ARTICLE

    Assessment of practices in screening and treating women with bacteriuria

    Erica L. Ditkoff1, Marissa Theofanides2, Carrie Mlynarczyk Aisen2, Casey G. Kowalik3, Joshua A. Cohn3, Wilson Sui3, Matthew Rutman2, Rony A. Adam4, Roger R. Dmochowski3, Kimberly L. Cooper2
    Canadian Journal of Urology, Vol.25, No.5, pp. 9486-9496, 2018
    Abstract Introduction: Evidence-based screening and treatment for bacteriuria is crucial to prevent increasing antibiotic resistance. The Infectious Disease Society of America (IDSA) previously released guidelines on the management of asymptomatic bacteriuria (ASB) and uncomplicated urinary tract infections (UTIs) in women. The study’s objective was to assess physicians’ practices in managing women with bacteriuria relative to these guideline recommendations.
    Materials and methods: Cross-sectional data from physicians were collected using an anonymous questionnaire. Multivariable logistic regression analyses identified independent predictors of adherence to guidelines.
    Results: Data were collected from 260 physicians. Over half of physicians surveyed were unfamiliar with IDSA guidelines… More >

  • Open AccessOpen Access

    ARTICLE

    Nephrostomy tube placement prior to percutaneous nephrolithotomy does not impact outcomes

    Priyanka Bearelly1,*, Claire Lis2,*, James Trussler2,, Mark H. Katz1, Richard K. Babayan1, David S. Wang1
    Canadian Journal of Urology, Vol.25, No.5, pp. 9497-9502, 2018
    Abstract Introduction: This study aims to compare outcomes of percutaneous nephrolithotomy (PCNL) performed with a nephrostomy tube placed prior to surgery versus access obtained at the time of surgery.
    Materials and methods: Between March 2005 and August 2014, 233 PCNLs were performed. One hundred and nine of those cases underwent placement of nephrostomy tubes at least 1 day prior to surgery (Group A), and the remaining 124 cases were performed in which access was obtained at the time of PCNL (Group B). Patient demographics, comorbidities, stone size, sepsis rates, and additional complication rates, including bleeding and inability to… More >

  • Open AccessOpen Access

    ARTICLE

    Laparoscopic heminephrectomy for duplex system: observed difference in outcomes between upper and lower pole resections

    Charlotte K. Roberts1, Jonathan S. Ellison2, Omar Aboumarzouk1, Mohamed Abd-Alazeez1, Francis X. Keeley, Jr1
    Canadian Journal of Urology, Vol.25, No.5, pp. 9503-9508, 2018
    Abstract Introduction: Renal duplication is a relatively common congenital abnormality of the urinary tract, but symptomatic duplex kidney is a rare presentation in adults. Traditionally, the treatment of choice for poorly functioning moiety has been heminephrectomy. There is extensive literature detailing the outcomes of minimally invasive upper pole heminephrectomy, but comparatively little published regarding lower pole resection, especially in adult patients. We present a series of 13 patients who underwent minimally invasive heminephrectomy for duplex kidney.
    Materials and methods: Over a 6-year period (2011-2017), 13 patients at a single center underwent laparoscopic heminephrectomy for symptomatic duplex kidney with… More >

  • Open AccessOpen Access

    ARTICLE

    Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database

    Daniel Taussky1,2, Felix Preisser3,4, Pierre I. Karakiewicz1,5, Derya Tilki3,4, Carole Lambert1,2, Jean-Paul Bahary1,2, Guila Delouya1,2, Robert Wistaff2,6, Mikhael Laskine2,6, Paul Van Nguyen2,6, Madeleine Durand2,6, Fred Saad5
    Canadian Journal of Urology, Vol.25, No.5, pp. 9509-9515, 2018
    Abstract Introduction: Conflicting data exists on the influence of metformin on prostate cancer. We investigated the importance of metformin in patients treated with radiotherapy or brachytherapy.
    Materials and methods: All patients from a large institutionalized database, treated for primary localized prostate cancer with either brachytherapy or external-beam radiotherapy ± androgen deprivation therapy were identified. Groups were compared by Kaplan–Meier analyses and Cox regression models. Multivariate analysis was adjusted for CAPRA-Score, type of treatment, and age.
    Results: A total of 2441 patients with complete data was identified. Among them, 382 patients (16% of total) were diabetic. Two hundred eighty-one of… More >

  • Open AccessOpen Access

    ARTICLE

    Survival and secondary interventions following treatment for locally-advanced prostate cancer

    Rachael Sussman1,2,*, Filipe L.F. Carvalho1,2,*, Andrew Harbin1, Choayi Zheng1, John H. Lynch1, Lambros Stamatakis2, Jonathan Hwang2, Stephen B. Williams3, Jim C. Hu4, Keith J. Kowalczyk1
    Canadian Journal of Urology, Vol.25, No.5, pp. 9516-9524, 2018
    Abstract Introduction: The utility of radical prostatectomy (RP) for locally-advanced prostate cancer remains unknown. Retrospective data has shown equivalent oncologic outcomes compared to radiation therapy (RT). RP may provide local tumor control and prevent secondary interventions from local invasion, and may decrease costs.
    Materials and methods: Using SEER-Medicare data from 1995-2011, we identified men with locally-advanced prostate cancer undergoing RP or RT. Rates of post-treatment diagnoses and interventions were identified using ICD-9 and CPT codes. Skeletal related events (SRE), androgen deprivation therapy (ADT) utilization, all-cause mortality, prostate cancer-specific mortality, and costs were compared.
    Results: A total of 8367 men… More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Ileal perforation in the setting of atezolizumab immunotherapy for advanced bladder cancer

    Jacqueline Zillioux1, Matthew DiLizia2, Basil Schaheen3, Rudolph Rustin3, Tracey L. Krupski1
    Canadian Journal of Urology, Vol.25, No.5, pp. 9525-9526, 2018
    Abstract Atezolizumab is a promising immunotherapy for advanced urothelial carcinoma. Like other immune checkpoint inhibitors, it can produce rare immune-related adverse events (IRAEs). Here we present the recent case of a patient with metastatic bladder cancer who developed diarrhea and abdominal pain months after beginning atezolizumab therapy. He presented to our institution with an ileal perforation secondary to atezolizumabinduced enterocolitis. After surgical repair, the patient’s condition improved, and he was discharged. We discuss the management of atezolizumab-induced enterocolitis, including the importance of early recognition and intervention to prevent more devastating complications. More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Epithelioid angiomyolipoma metastasis to the rectus abdominis

    Edward J. Park1, Arden Plumb2, Ryan Powers1, Patricia Vidal1,3, Sarah Psutka1,3
    Canadian Journal of Urology, Vol.25, No.5, pp. 9527-9529, 2018
    Abstract A 37-year-old female presented with abdominal pain. An abdominal computed tomography scan demonstrated a 10 cm x 13 cm left renal mass. An open adrenal-sparing radical nephrectomy was performed. The pathological diagnosis was epithelioid angiomyolipoma. Five-year surveillance did not demonstrate recurrence of disease. However, a 1.8 cm x 2.5 cm mass on the rectus abdominis muscle was identifed after 5 years. Biopsy of the mass demonstrated histologic findings consistent with the primary tumor. Herein, we report a case of metastatic renal epithelioid angiomyolipoma to the rectus abdominis muscle more than 5 years after resection of More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Primitive neuroectodermal tumor arising from an untreated congenital undescended testicle

    Mounsif Azizi, Charles C. Peyton, Philippe E. Spiess
    Canadian Journal of Urology, Vol.25, No.5, pp. 9530-9533, 2018
    Abstract A 26-year-old male with a personal history of schizophrenia initially presented with a 13 cm pelvic mass corresponding to a cryptorchidic testis. The patient was treated with primary and second-line chemotherapy for metastatic germ-cell tumor followed by surgical consolidation. Final pathology revealed a primitive neuroectodermal tumor (PNET) mixed with mature teratoma. Despite multidisciplinary management, significant patient noncompliance led to inadequate follow up and treatment delays ultimately resulting in death. To our knowledge, this is the only reported case of teratoma with malignant transformation arising from an untreated congenital undescended testicle. More >

  • Open AccessOpen Access

    ABSTRACT

    Abstracts of the Mid-Atlantic Section of the American Urological Association Annual Meeting October 4 - 7, 2018 Washington, DC


    Canadian Journal of Urology, Vol.25, No.5, pp. 9534-9567, 2018
    Abstract This article has no abstract. More >

Per Page:

Share Link